June 20, 2022 | 11:01
Sanofi-Aventis Vietnam on June 17 entered a cooperation agreement with FPT Long Chau to implement the Insulin Pen Sustainability Pilot Project.
May 17, 2022 | 10:00
Although legal issues remain in some areas, public-private collaboration continues to be a focus among multinational corporations in Vietnam’s healthcare sector, and further expansions are being sought.
March 14, 2022 | 07:00
Sanofi unveiled a new bold and unifying corporate brand that supports the modernisation and transformation the company launched in December 2019.
March 02, 2022 | 09:51
Sanofi and GSK on February 23 announced that they intend to submit data from both their booster and phase 3 efficacy trials as the basis for regulatory applications for a COVID-19 vaccines.
December 13, 2021 | 08:04
Sanofi Vietnam signed an MoU with BSB Nanotech to develop a new model of circular economy through the “Rice is the new green” sustainability project.
November 18, 2021 | 17:00
A number of multinational corporations are planning to venture further into local production to enjoy incentives and to benefit from the landmark EU-Vietnam Free Trade Agreement.
November 12, 2021 | 09:25
The presence of Prime Minister Pham Minh Chinh and the high-level Vietnamese government delegation at the signing ceremony of Vietnam Pharmaceutical Corporation (Vinapharm) and Sanofi’s cooperation..
October 30, 2021 | 17:07
Four senior leaders of Sanofi Vietnam have been recognised at the prestigious Vietnam Excellence awards for their success in transforming business.
September 24, 2021 | 11:12
Sanofi Vietnam and GIZ signed an agreement on cooperation in implementing the "Rice is the new green" project.
September 20, 2021 | 09:00
Driven by people-centric business administration, Sanofi is bringing out the best in its people and helping improve people’s accessibility to vaccines worldwide.
April 26, 2021 | 15:00
Amid the continuous development of COVID-19 globally, French drugmaker Sanofi is seeking to fulfil its ambition of empowering people this year and beyond.
December 10, 2020 | 10:00
Multinationals like Sanofi, GSK, Adamed Pharma, and Merck Sharp & Dohme have requested marketing authorisation withdrawal of some pharmaceuticals, with it being unclear if the quality of some popular items is an underlying issue.
September 04, 2020 | 15:00
Burning to take advantage of Vietnam’s new digital transformation in the healthcare sector, international pharma giants like Novartis, AstraZeneca, Sanofi, and GSK are working to align with the new requirements and obtain sustainable gains.
August 13, 2020 | 08:00
Amidst lower-than-expected business performance, international pharma giants are betting on COVID-19 vaccine sales, hoping to alter the headwinds from the health crisis to their advantage.
July 08, 2020 | 09:00
Amid ongoing revision of the regulation of drug tenders at public hospitals, multinational corporations are renewing efforts to have EU-GMP standards for their manufacturing sites acknowledged in Vietnam to qualify for the most lucrative tenders.